XML 54 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
(LOSS) / INCOME PER COMMON SHARE - Additional Information (Details) - $ / shares
3 Months Ended 9 Months Ended
May 16, 2017
Jan. 05, 2017
Dec. 07, 2016
Sep. 09, 2016
Jun. 24, 2015
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
RSU's                  
Antidilutive securities excluded from computation of earnings per share                  
Number of potentially dilutive securities that were determined to be anti-dilutive (in shares)           800,047 1,072,948 733,439 1,072,948
RSU's | 2012 Equity Incentive Plan                  
Antidilutive securities excluded from computation of earnings per share                  
Issuance of common stock for vested 2015 and 2016 restricted stock units (in shares)     278,483            
Shares forfeited to date               44,919  
Shares remaining to be issued in future years (in shares)           635,518   635,518  
Granted (in shares)         1,663,660     45,000  
RSU's | 2012 Equity Incentive Plan | Non Employee Director                  
Antidilutive securities excluded from computation of earnings per share                  
Issuance of common stock for vested 2015 and 2016 restricted stock units (in shares) 28,752     28,752          
Vesting period of shares 30 days                
Granted (in shares) 44,856     28,752          
Granted (in dollars per share) $ 5.35     $ 6.26          
Stock options                  
Antidilutive securities excluded from computation of earnings per share                  
Number of potentially dilutive securities that were determined to be anti-dilutive (in shares)             309,296 309,296 309,296
Number of potentially dilutive securities excluded from EPS calculation as certain market conditions have not been met (in shares)             13,420 13,420 13,420
Stock options | Mr. Georgiopoulos                  
Antidilutive securities excluded from computation of earnings per share                  
Options granted (in shares)   500,000              
Stock options | Leonard J. Vrondissis                  
Antidilutive securities excluded from computation of earnings per share                  
Options granted (in shares)   25,000